Many DNA biomarkers for cancer in human medicine are now commonly used in commercial test kits, highlighting their successful application after initial identification as biomarkers [41,42]; e.g., VIM gene (vimentin) is used for diagnosis of colorectal cancer in a commercially available kit known as “Cologuard” and marketed by Exact Sciences [43]. This evidence concerns the gene VIM and cancer.